MACCIONI, ELIAS
 Distribuzione geografica
Continente #
EU - Europa 251.751
NA - Nord America 8.335
AS - Asia 1.116
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 7
OC - Oceania 3
Totale 261.236
Nazione #
IT - Italia 249.142
US - Stati Uniti d'America 8.278
UA - Ucraina 944
CN - Cina 893
SE - Svezia 728
DE - Germania 347
FI - Finlandia 237
GB - Regno Unito 206
FR - Francia 65
SG - Singapore 56
VN - Vietnam 53
CA - Canada 47
IN - India 43
HK - Hong Kong 27
RU - Federazione Russa 26
PK - Pakistan 18
BE - Belgio 17
IR - Iran 13
EU - Europa 7
EG - Egitto 6
MX - Messico 6
PT - Portogallo 6
ES - Italia 5
IE - Irlanda 5
NL - Olanda 5
RO - Romania 5
CL - Cile 4
ID - Indonesia 3
MA - Marocco 3
MU - Mauritius 3
TN - Tunisia 3
TR - Turchia 3
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HR - Croazia 2
JP - Giappone 2
MD - Moldavia 2
PL - Polonia 2
A1 - Anonimo 1
AT - Austria 1
BO - Bolivia 1
CM - Camerun 1
CO - Colombia 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
Totale 261.236
Città #
Cagliari 248.596
Fairfield 988
Chandler 863
Woodbridge 846
Houston 641
Ann Arbor 529
Nyköping 523
Ashburn 495
Jacksonville 491
Wilmington 410
Seattle 395
Dearborn 378
Cambridge 302
Nanjing 167
New York 159
Boardman 158
Beijing 141
Boston 122
Helsinki 105
Shanghai 96
Redwood City 64
Shenyang 58
Nanchang 54
Dong Ket 53
San Diego 50
Guangzhou 41
Hebei 41
Changsha 39
Toronto 39
Sassari 37
Jiaxing 36
Jinan 31
Milan 29
Mountain View 29
Verona 28
Kunming 25
Herndon 24
Norwalk 24
Tianjin 23
Hong Kong 20
Auburn Hills 18
Los Angeles 18
Zhengzhou 18
Brussels 17
London 17
Orange 17
Taizhou 17
Atlanta 16
Hangzhou 16
Hefei 15
Washington 15
Ningbo 13
Pune 13
Rome 13
Phoenix 12
Falls Church 11
Mumbai 9
Redmond 9
Olbia 8
Quartu Sant'elena 8
Saint Petersburg 8
Gujranwala 7
Indiana 7
Quartu Sant'Elena 7
San Francisco 6
Walnut 6
Zerfalìu 6
Borås 5
Chicago 5
Islamabad 5
Nürnberg 5
Paris 5
Siracusa 5
Yellow Springs 5
Baotou 4
Central 4
Cosenza 4
Fuzhou 4
Millbury 4
Napoli 4
Ottawa 4
Bultei 3
Cairo 3
Chengdu 3
Dublin 3
Jakarta 3
Kilburn 3
La Jolla 3
Rabat 3
Rockville 3
Villanovafranca 3
Wuhan 3
Acton 2
Ardabil 2
Barcelona 2
Berlin 2
Calasetta 2
Chisinau 2
Decimomannu 2
Dolianova 2
Totale 257.589
Nome #
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 4.419
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies 4.142
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 4.141
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.089
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.088
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 3.967
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 3.845
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 3.793
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 3.706
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.619
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 3.559
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 3.555
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.501
N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors 3.390
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.357
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 3.224
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.223
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 3.173
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.147
N-alkylamides from Otanthus maritimus: structure elucidation, binding affinity for cannabinoid receptors and computational study 3.142
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.123
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.071
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.064
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 2.933
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 2.918
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 2.918
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 2.917
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 2.826
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 2.671
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 2.671
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.662
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 2.656
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.629
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.624
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 2.600
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 2.586
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.578
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.535
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 2.493
MD protocol validation for the study of MAOB-inhibitor complexes 2.457
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.421
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.394
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.393
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 2.337
Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations 2.315
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.293
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.279
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 2.251
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.216
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.200
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.199
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.145
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.112
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.030
New promising scaffolds for the inhibition of monoamine oxidase B 2.014
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 1.985
null 1.949
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 1.838
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 1.829
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 1.826
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 1.783
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 1.773
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.736
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 1.722
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.718
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.697
Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors 1.687
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.675
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.667
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.635
Application of an immobilised amylose-based chiral stationary phase to the development of new monoamine oxidase B inhibitors 1.618
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.524
null 1.499
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.485
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.468
New reactions of carbon suboxide with alkines 1.452
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.426
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.418
null 1.415
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.411
null 1.406
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.395
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.340
From classic to innovative approaches in HIV-1 infection treatment 1.310
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.298
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.278
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.277
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.218
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 1.171
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.144
9-fluorenones as new scaffolds for G-quadruplex DNA 1.059
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 993
Design, synthesis and biological evaluation of new fluorenone derivatives as DNA G-quadruplex binders 968
null 943
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 931
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 927
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 911
A combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening for the identification of dual inhibitors targeting HIV-1 reverse transcriptase. 908
Progettazione e sintesi di 4-(5-ariliden-3-metil-4-ossotiazolidin-2-ilidenamino)benzensulfonamidi e 4-(5-alchiliden-3-metil-4-ossotiazolidin-2-ilidenammino)benzensulfonamidi quali potenziali inibitori selettivi delle ciclossigenasi 2 905
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 893
Totale 225.122
Categoria #
all - tutte 295.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 295.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.856 0 0 0 0 0 0 0 0 0 0 1.148 708
2019/202048.187 2.418 2.027 397 1.110 15.487 11.725 6.379 1.440 1.197 1.643 1.621 2.743
2020/202172.917 2.647 2.691 3.944 17.633 13.665 8.290 6.218 4.614 1.996 4.479 4.401 2.339
2021/202213.818 1.686 1.202 696 957 1.162 915 866 728 1.314 1.349 1.384 1.559
2022/202323.088 2.100 3.430 2.873 2.196 1.543 2.494 1.272 1.639 1.232 1.295 1.840 1.174
2023/202419.954 1.091 689 2.078 1.827 2.342 3.910 2.893 1.617 1.189 1.334 984 0
Totale 261.719